This discussion is concerned with treatment. Treatment is sometimes directed at the patient, sometimes at the disease, sometimes at the patient's relatives, sometimes at the general public and sometimes at the doctor himself. Most of the bad management in hypertension comes from treating the public, as represented by insurance companies, or the 'disease', or the doctor himself, as represented by his built-in prejudice. In no other malady is it more essential that treatment should be directed to the patient.
This discussion is concerned with treatment. Treatment is sometimes directed at the patient, sometimes at the disease, sometimes at the patient's relatives, sometimes at the general public and sometimes at the doctor himself. Most of the bad management in hypertension comes from treating the public, as represented by insurance companies, or the 'disease', or the doctor himself, as represented by his built-in prejudice. In no other malady is it more essential that treatment should be directed to the patient.
Most of the mismanagement comes from the false idea that a dividing line can properly be drawn between normal blood pressure and hypertension. On the one side is health, on the other side is disease. If figures are obtained on the pathological side, then insurance becomes difficult or impossible, firms refuse to make appointments, the doctor is scared and the patient is scared. Two pieces of evidence demonstrate how nonsensical this dividing line is: (1) When the blood pressure is recorded automatically at five minute intervals in a normal subject the variation is immensefrom 130 to 165 systolic. (2) The dividing line which has been chosen by wellknown authorities varies from 120/80 to 180/110. There is no evidence for such dividing lines, which are obviously arbitrary. When blood pressure is measured in a sample of the population, the mean value for systolic and diastolic rises with age and more in females than in males. Frequency distribution curves show that there is no natural dividing line and that the rise of blood pressure with age is greater in some subjects than others. A comparison with the close relatives of subjects with essential hypertension shows that those relatives have higher pressures at all ages. The rate of rise of pressure with age is the same in the relatives of subjects with essential hypertension as in subjects without hypertension. What is inherited is not the rate of rise of pressure with age, but the tendency to have high pressures at all ages.
Biometrical analysis shows that the resemblance between close relatives in families derived from hypertensive patients is quantitative. The resemblance measured by the regression coefficient is a little over 0-2. Miall & Oldham (1958) , in a most painstaking and exhaustive investigation and analysis, have shown beyond all reasonable doubt that in the population at large arterial pressure is inherited as a graded character and that the degree of resemblance measured by the regression coefficient is again a little over 0 2. Thus it seems that blood pressure is inherited in the same way in the ranges commonly called normotension and hypertension.
If one studies the relationship between blood pressure and its consequences, the relationship is again quantitative. Even in the ranges which the insurance companies have regarded as normal this is so, and the relationship continues in the same pattern through the highest values in the pathological range. This holds good for expectation of life, frequency of cardiovascular renal disease, and survival of children after delivery from women with raised pressure. Thus, the dividing lin'e between normotension and hypertension is nothing more or less than an artifact. There is no justification whatsoever for regarding the transition between, say, 140 and 160 as having any special significance. The fact is that the higher the arterial pressure the less the expectation of life, but this is true throughout the range.
Expectation of life is also affected by other things, for example family history, blood cholesterol, and those effects on the cardiovascular system which have already happened. These must be taken into account when deciding whether to institute drug therapy. The early phenomena of malignant hypertension, cardiac asthma and hypertensive fits are absolute indications.
The most important function of the doctor is to rid his patient of fear. One of the most evil consequences of this erroneous hypothesis that hypertension represents a disease sharply distinguishable from normality and that patients have it if their pressure exceeds, say 150 systolic, is that patients are all too frequently frightened by their doctors because their arterial pressure exceeds an arbitrary value. This false hypothesis was resuscitated a few years ago, but I am glad to say that the evidence for it has not withstood critical examination and it is now quite unsupported by evidence. Nevertheless, its adherents still cling to it to the detriment of their patients' welfare and happiness. It The objectives of treatment of patients suffering from raised blood pressure fall into three categories: (1) Reduction in blood pressure, (2) relief of symptoms, and (3) prevention of the complications of hypertension. Patients with hypertension fall mainly into two groups: the younger patient, in whom comprehensive hospital investigation is obligatory, and the elderly patient, usually with a mild degree of hypertension, who is mainly treated by the general practitioner. In elderly patients the relief of symptoms may be of more importance than the achievement of normoten-sion, and indeed the latter procedure may bring its own hazards. Hypotensive regimes which may be highly satisfactory in hospital are not always best suited to the ambulant patient who must earn his living. The occurrence of side-effects, or inconvenient therapeutic regimes, may result in alternative choices of drugs for domiciliary use; drugs particularly suitable and convenient for use in general practice are guanethidine, methyldopa, reserpine and derivatives and the oral diuretics, either singly or in combination. With these drugs it is usually possible to obtain some hypotensive effect.
Reduction in BloodPressure
The flrst criterion of successful hypotensive treatment is a reduction in blood pressure readings. The extent to which a hypotensive effect can be achieved in ambulant patients in general practice is illustrated by three trials which have been undertaken by the General Practitioner Research Group, involving a total of 175 cases of hypertension. In the first trial the effect of methoserpidine was measured in 55 patients over a period of four months. The results achieved are shown in Table 1 .
As the average figure will be influenced by the number of patients in whom there was no fall in blood pressure, for a full assessment of the hypotensive action of this drug it is also necessary to know the proportion of patients in whom blood pressure fell. Of all the patients treated, at the tenweek period 71 % had experienced a fall of diastolic pressure of 10-15 mm Hg, and this included 37 % of the total who had experienced a fall of 20 mm Hg or more.
The next trial concerned the use of a new oral diuretic, polythiazide, which is claimed to have a specific hypotensive effect. There were 65 patients in this trial: polythiazide was the sole treatment in 35, of whom 30 had not previously been treated; in the remaining 30 patients, polythiazide was given with reserpine, 17 being already under treatment with reserpine. Fig 1 shows the Table 1 Average fall in blood pressure following use of methoserpidine 
